Special Issue "Antimicrobial Properties of Natural Products"
Deadline for manuscript submissions: 31 December 2019
Prof. Dr. Raphaël E. Duval PhD, PharmD
Antimicrobial resistance has become a major public health issue during these last years. According to a (very) recent study published in LID , multidrug-resistant bacteria were responsible for 30,000 deaths in Europe alone in 2015. Antibacterial resistance is such that there is a real risk of reaching a therapeutic dead end in which there are no longer effective molecules for treating infectious diseases. Furthermore, this situation is global, since we also find antimicrobial resistance in fungi or viruses. Bearing in mind that the therapeutic arsenal that we have at our disposal to fight against fungal and viral infections (excluding HIV and HCV) is very limited, it is therefore urgent to look for new antimicrobial molecules. Concomitantly, and for several years now, the search for natural compounds with antimicrobial activities has been a growing field of research.
The aim of this Special Issue is to highlight recent advances in research on natural products with antimicrobial properties (i.e., antibacterial, antiviral, or antifungal). This Special Issue may include original research articles and reviews on the antimicrobial properties of extracts, fractions, purified compounds, synergistic mixtures against bacteria, viruses, or fungi encountered in human infectious diseases, to identify promising natural compounds that could allow us to respond to the urgency of finding new antimicrobials.
Prof. Dr. Raphaël E. Duval
1. Cassini A., Högberg L.D., Plachouras D., Quattrocchi A., Hoxha A., Simonsen G.S., Colomb-Cotinat M., Kretzschmar M.E., Devleesschauwer B., Cecchini M., Ait Ouakrim D., Oliveira T.C., Struelens M.J., Suetens C., Monnet D.L. and the Burden of AMR Collaborative Group. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. http://dx.doi.org/10.1016/S1473-3099(18)30605-4
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Natural products